Understanding individual risk and predictability of severe COVID-19

CiiM is involved in the establishment of a COVID-19 patient cohort. The project, led by Prof. Dr. Thomas Illig from the Hannover Unified Biobank (MHH), is funded by the state of Lower Saxony. The project is carried out by an interdisciplinary consortium of scientists and physicians from the MHH, the Hannover Region Hospital (KRH) and the Helmholtz Centre for Infection Research.

A total of € 2.03 million will support the establishment of a cohort of COVID-19 patients and corresponding controls with standardised, longitudinal collection of biological material for subsequent molecular characterisation. The comprehensive characterisation will allow to better understand the pathophysiology of the disease and detect biomarkers for severity and associated metabolic pathways as well as therapeutic options for the disease.


Prof Dr Markus Cornberg
Prof Dr Markus Cornberg
CiiM Director - CiiM
Immunology of Viral Hepatitis and Infections in Liver Cirrhosis